Curaleaf Unveils New Plan to Manage Executive Securities Disposition Efficiently

Curaleaf Implements Automatic Securities Disposition Plan

Curaleaf Holdings, Inc., a prominent player in the cannabis industry based in Stamford, Connecticut, has made a significant announcement regarding its executive management strategies. Effective March 31, 2026, the company revealed that its Chief Legal Officer, Peter Clateman, has extended an already existing Automatic Securities Disposition Plan (ASDP). This strategic move is designed to ensure compliance with the regulations set forth by both United States and Canadian securities laws, in conjunction with the firm's internal trading policies.

The ASDP is constructed to facilitate a systematic exercise of stock options that are on the verge of expiration in July 2027. It will also enable Mr. Clateman to sell a portion of the subordinate voting shares he currently holds. These sales are intended to assist in covering the anticipated tax liabilities associated with the disposal of these shares. Sales are expected to begin around July 1, 2026, and will be executed over a six-month period.

What makes the ASDP particularly noteworthy is that the transactions will be handled by an independent securities broker. This ensures that all sales adhere to predetermined trading parameters, including pricing and volume limitations, as well as various restrictions outlined in the ASDP. The establishment of this plan was supervised by the company's compensation committee, demonstrating a commitment to transparency and due diligence, especially as it was put into action prior to the onset of a blackout period which usually restricts trading activities for insiders and executives.

Each sale executed under the ASDP will be reported in compliance with applicable securities regulations, making the process transparent for investors. Notably, each filing will include a note indicating that the sale pertains to the ASDP, which should provide additional clarity to stakeholders regarding the nature of these transactions.

Curaleaf's holistic approach to corporate governance and compliance underlines its status as a leading international cannabis provider. Founded with a mission to improve lives by harnessing the power of cannabis products, Curaleaf not only focuses on maintaining high standards in quality and service but also is committed to responsible governance practices. This ASDP is just one of the many steps the company has taken to promote ethical management while ensuring shareholder interests are safeguarded.

Moreover, Curaleaf has built a robust presence in the cannabis sector. With a diverse portfolio encompassing major brands such as Curaleaf, Select, Grassroots, Find, and Anthem, the company has distinguished itself not just through product offerings but also via its innovative distribution network across Europe, Canada, and Australasia. This multi-faceted approach enables Curaleaf to merge cutting-edge research and cultivation techniques with a wide range of consumer products in the medical and adult-use markets.

As the cannabis landscape continues to evolve, Curaleaf remains at the forefront, adapting to market demands while adhering to regulatory requirements. The introduction of the ASDP is a step towards enhancing operational efficiency and investor confidence as the company navigates an increasingly complex market environment. By prioritizing transparency and compliance, Curaleaf sets a high-standard framework not only for its operations but also for the broader cannabis industry.

For those interested in following Curaleaf's journey, further details about the ASDP and other corporate disclosures are readily accessible through the company's profile on the SEDAR website, reinforcing Curaleaf's commitment to transparency and stakeholder engagement. The company's continued growth and adaptation reflect its dedication to integrating compliance with strategic business development in the booming cannabis market.